Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B (TERESA)

This study has been completed.
Information provided by (Responsible Party):
Young-Suk Lim, Asan Medical Center Identifier:
First received: May 8, 2012
Last updated: June 24, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)